Review on the production and applications of gold nanoparticles as a drug delivery carrier
Keywords:
Gold nanoparticles, Anti-cancer, tumour medicinesAbstract
There are numerous medicinal and industrial uses for nanoparticles in the detection and treatment of disease. Nanoparticles stand out for their ability to perform multiple tasks and their small size. It is possible to use nanoparticles to deliver drugs to specific sites in the body, as well as to increase cellular absorption. Gold nanoparticles, which are the most extensively investigated of all metallo-nanoparticles, are the focus of this review. Anti-cancer medications are available; however, necrosis of both malignant and non-cancerous cells is a side effect of many of them. The necrosis caused by gold nanoparticles affects exclusively cancer cells. Smaller than human cells, these tailored drug delivery devices can quickly infiltrate tumors and kill malignant cells. Anticancer medicines that have been conjugated with gold nanoparticles are more effective. Due to their photophysical and optical properties, gold nanoparticles are useful in chemotherapy and cancer diagnostics. Proteins, peptides, and nucleic acids can all be used to modify gold nanoparticles. Such devices have a wide range of applications, from biosensors to medication administration.
Downloads
References
Cai, W. and X. Chen, 2007. Nanoplatforms for targeted molecular imaging in living subjects. Small, 3: 1840-54.
Li, L., M. Fan, R. Brown, L.J. Van, J. Wang W. Wang, Y. Song and P. Zhang, 2006. Synthesis, Properties and environmental applications of nanoscale iron-based materials; a review. EnViron. Sci. Technol., 36: 405-431.
El-Sayed, I., X. Huangand, A.M. El-Sayed, 2006. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Letter, 2: 129-135.
Alvarez, M.M., J.T. Khoury, T.G. Schaaff, M.N. Shafigullin, I. Vezmar and R.L. Whetten, 1997. Optical absorption spectra of Nanocrystal gold molecules. Phys. Chem., 101: 3706-3712. 5.
Bhattacharya, S. and A. Srivastava, 2003. Synthesis of gold nanoparticles stabilised by metal-chelator and the controlled formation of close-packed aggregates by them. Proc. Indian acad. Sci. (Chem. Sci.), 115: 613-619.
Jadzinsky, P.D., G. Calero, C.J. Ackerson, D.A. Bushnell and R.D. Kornberg, 2007. Structure of a Thiol Monolayer-Protected Gold Nanoparticle at 1.1 Å Resolution. Science, 318: 430-433
Aryal, S., J.J. Grailer, S. Pilla, D.A. Steeber and S. Gong, 2009. Doxorubicin conjugated gold nanoparticles as water-soluble and pH-responsive anticancer drug nanocarriers, J. Mater. Chem, 19: 7879-7884.
Bowman, M., T.E. Ballard, C.J. Ackerson, D.L. Feldheim, D.M. Margolis and C. Melander, 2008. Inhibition of HIV Fusion with Multivalent Gold Nanoparticles. J. Am. Chem. Soc., 130: 6896-6897.
Shenoy, D., W. Fu, J. Li, C. Crasto, J. Graham, D. Charles, S. Srinivas and A. Mansoor, 2005. Surface-Functionalized Gold Nanoparticles. International Journal of Nanomedicine, pp: 1-4.
Connor, E.E., J. Mwamuka, A. Gole, J. Murphy and M. Wyatt, 2005. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small, 1: 325-327.
Mfhlen, K., K. Hand and F. Beller, 1979. 18. Ducan, B., K. Chaekyu and V.M. Rotello, 2010.
Use of radioactive gold in the treatment of pleural gold nanoparticle platforms as drug and effusions caused by metastatic cancer. J. Cancer Res. biomolecule delivery systems, Journal of Controlled Clin. Oncol, 94: 81-85. Release, 148: 122-127.
Chah, S., R.M. Hammond and N.R. Zare, 2005. 19. Verma, A., J.M. Simard, J.W.E. Worrall and
Gold nanoparticles as a colorimetric sensor for V.M. Rotello, 2004. Tunable reactivation protein conformational changes. Chem Biol., ofnanoparticle-inhibited beta-galactosidase by 323-328. glutathione at intracellular concentrations. J. Am.
Cai, W., T. Gao, H. Hong and J. Sun, 2008. Chem. Soc, 126: 13987-13991. Application of gold nanoparticles in cancer 20. Bhumkar, D.R., H.M. Joshi, M. Sastry and nanotechnology. Nanotechnology, Science and V.B. Pokharkar, 2007. Chitosan reduced Applications, 1: 17-32. goldnanoparticles as novel carriers for transmucosal
Low, A. and V. Bansal, 2010. A visual tutorial on delivery of insulin, Pharm. Res., 24: 1415-1426. the synthesis of gold nanoparticles. Biomedical 21. Angelatos, A.S., B. Radt and F. Caruso, 2005. Imaging and Intervention Journal, 6: 1-9.
Brust, M., M. Walker, D. Bethell, D.J. Schiffrin and R. Whyman, 1994. Synthesis of thiol derivatized gold 22. Brannon-Peppas, L. and J.O. Blanchette, 2004. nanoparticles in a 2-phase liquid-liquid system, Nanoparticle and targeted systems for J. Chem. Soc.,Chem. Commun, 7: 801-802.
Templeton, C.A., M.P. Wuelfing and R.W. Murray, 56: 1649-1659. 2000. Monolayer protected clustermolecules, Acc. 23. Brigger, I., C. Dubernet and P. Couvreur, 2002. Chem. Res., 33: 27-36.
Fan, J., S.W. Chen and Y. Gao, 2003. Coating gold Adv. Drug Delivery Review, 54: 631-651. nanoparticles with peptide molecules via apeptide 24. Baban, D. and L.W. Seymour, 1998. Control of tumour elongation approach, Colloids Surf, B Bio interfaces, vascular permeability, Adv. Drug Deliv. Rev., 28: 199-207.
Rakhmonov, O. M., Shadmanov, A. K., & Juraev, F. M. (2021). Results of endoscopic treatment of benign prostatic hyperplasia in patients with metabolic syndrome. International Journal of Health & Medical Sciences, 5(1), 21-25. https://doi.org/10.21744/ijhms.v5n1.1811
Ducan, B., K Chackyu and VM. Rotello, 2010, Gold nanoparticle platforms as drug and biomolecule delivery systems, Journal of Controlled Release, 148: 122-127.
Verna, A, JM. Simard, JWE Worrall and VM. Rotello, 2004 Tunable reactivation of nanoparticle-inhibited beta-galactosidase by glutathione at intracellular concentrations. J. Am. Chem. Soc, 126: 13987-13991.
Bhumkar, DR, HM Joshi, M. Sastry and VB. Pokharkar, 2007. Chitosan reduced goldnanoparticles as novel carriers for transmucosal delivery of insulin, Pharm Res., 24: 1415-1426.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864
Angelatos, A.S., B. Radt and F. Caruso, 2005. Light-responsive polyelectrolyte/gold nanoparticles microcapsules, J. Phys. Chem., 109: 3071-3076.
Brannon-Peppas, L. and J.O. Blanchette, 2004. Nanoparticle and targeted systems for cancertherapy, Adv. Drug Delivery Review, 56: 1649-1659
Brigger, I, C. Dubernet and P. Couvreur, 2002. Nanoparticles in cancer therapy and diagnosis, Adv. Drug Delivery Review, 54: 631-651.
Baban, D. and L. W. Seymour, 1998. Control of tumour vascular permeability, Adv. Drug Deliv. Rev.,34: 109-119.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
